Tissue content of DA and its metabolites (pg/mg) and the ratio DOPAC/DA in various brain regions of WT and Snord115-KO mice
. | DA . | DOPAC . | HVA . | DOPAC/DA . | ||||
---|---|---|---|---|---|---|---|---|
region . | WT . | SNORD . | WT . | SNORD . | WT . | SNORD . | WT . | SNORD . |
OF | 10.8 ± 1.2 | 11.2 ± 0.96 | 26 ± 3 | 25 ± 3 | 69 ± 10 | 45 ± 3* | 2.48 ± 0.2 | 2.36 ± 0.31 |
PL | 41 ± 5 | 29 ± 4 | 17 ± 2 | 16 ± 3 | 116 ± 8 | 86 ± 11* | 0.54 ± 0.08 | 0.55 ± 0.05 |
aCg | 89 ± 12 | 80 ± 7 | 75 ± 9 | 67 ± 7 | 213 ± 23 | 201 ± 24 | 0.79 ± 0.09 | 0.84 ± 0.08 |
NAC | 1591 ± 266 | 1544 ± 215 | 904 ± 136 | 1036 ± 109 | 601 ± 112 | 620 ± 59 | 0.6 ± 0.05 | 0.76 ± 0.11 |
DMS | 4107 ± 356 | 4535 ± 1047 | 1561 ± 162 | 1496 ± 195 | 670 ± 74 | 723 ± 143 | 0.36 ± 0.03 | 0.39 ± 0.04 |
DLS | 6064 ± 666 | 5028 ± 176 | 802 ± 92 | 790 ± 82 | 500 ± 60 | 448 ± 20 | 0.13 ± 0.01 | 0.15 ± 0.01 |
Th | 6 ± 0.9 | 8 ± 1 | 20 ± 1 | 22 ± 2 | 72 ± 8 | 77 ± 6 | 3.85 ± 0.58 | 2.67 ± 0.22 |
AM | 240 ± 54 | 287 ± 48.8 | 83 ± 19 | 121 ± 26 | 150 ± 22.6 | 215 ± 49 | 0.33 ± 0.05 | 0.46 ± 0.09 |
dH | 48 ± 6 | 44 ± 4 | 13 ± 1.8 | 13 ± 2 | 39 ± 3.78 | 41.8 ± 5.3 | 0.3 ± 0.03 | 0.3 ± 0.02 |
VTA | 215 ± 41 | 234 ± 38 | 191 ± 37 | 207 ± 27 | 205 ± 30.1 | 239 ± 18.8 | 0.88 ± 0.05 | 0.91 ± 0.06 |
SN | 259 ± 54 | 223 ± 46 | 141 ± 15 | 136 ± 21 | 265 ± 36 | 252 ± 40.3 | 0.64 ± 0.04 | 0.76 ± 0.04* |
vY | 128 ± 19 | 106 ± 14 | 105 ± 8 | 101 ± 13.1 | 171 ± 18.8 | 136 ± 16.9 | 0.98 ± 0.07 | 0.99 ± 0.08 |
. | DA . | DOPAC . | HVA . | DOPAC/DA . | ||||
---|---|---|---|---|---|---|---|---|
region . | WT . | SNORD . | WT . | SNORD . | WT . | SNORD . | WT . | SNORD . |
OF | 10.8 ± 1.2 | 11.2 ± 0.96 | 26 ± 3 | 25 ± 3 | 69 ± 10 | 45 ± 3* | 2.48 ± 0.2 | 2.36 ± 0.31 |
PL | 41 ± 5 | 29 ± 4 | 17 ± 2 | 16 ± 3 | 116 ± 8 | 86 ± 11* | 0.54 ± 0.08 | 0.55 ± 0.05 |
aCg | 89 ± 12 | 80 ± 7 | 75 ± 9 | 67 ± 7 | 213 ± 23 | 201 ± 24 | 0.79 ± 0.09 | 0.84 ± 0.08 |
NAC | 1591 ± 266 | 1544 ± 215 | 904 ± 136 | 1036 ± 109 | 601 ± 112 | 620 ± 59 | 0.6 ± 0.05 | 0.76 ± 0.11 |
DMS | 4107 ± 356 | 4535 ± 1047 | 1561 ± 162 | 1496 ± 195 | 670 ± 74 | 723 ± 143 | 0.36 ± 0.03 | 0.39 ± 0.04 |
DLS | 6064 ± 666 | 5028 ± 176 | 802 ± 92 | 790 ± 82 | 500 ± 60 | 448 ± 20 | 0.13 ± 0.01 | 0.15 ± 0.01 |
Th | 6 ± 0.9 | 8 ± 1 | 20 ± 1 | 22 ± 2 | 72 ± 8 | 77 ± 6 | 3.85 ± 0.58 | 2.67 ± 0.22 |
AM | 240 ± 54 | 287 ± 48.8 | 83 ± 19 | 121 ± 26 | 150 ± 22.6 | 215 ± 49 | 0.33 ± 0.05 | 0.46 ± 0.09 |
dH | 48 ± 6 | 44 ± 4 | 13 ± 1.8 | 13 ± 2 | 39 ± 3.78 | 41.8 ± 5.3 | 0.3 ± 0.03 | 0.3 ± 0.02 |
VTA | 215 ± 41 | 234 ± 38 | 191 ± 37 | 207 ± 27 | 205 ± 30.1 | 239 ± 18.8 | 0.88 ± 0.05 | 0.91 ± 0.06 |
SN | 259 ± 54 | 223 ± 46 | 141 ± 15 | 136 ± 21 | 265 ± 36 | 252 ± 40.3 | 0.64 ± 0.04 | 0.76 ± 0.04* |
vY | 128 ± 19 | 106 ± 14 | 105 ± 8 | 101 ± 13.1 | 171 ± 18.8 | 136 ± 16.9 | 0.98 ± 0.07 | 0.99 ± 0.08 |
All values are expressed as mean ± SEM (pg/mg of tissue for individual compounds) except the ratio. Significance is indicated as follows: *P < 0.05 (Students t-test). (n = 8–10 except in the DL where n = 5 due to an experimental error).
Tissue content of DA and its metabolites (pg/mg) and the ratio DOPAC/DA in various brain regions of WT and Snord115-KO mice
. | DA . | DOPAC . | HVA . | DOPAC/DA . | ||||
---|---|---|---|---|---|---|---|---|
region . | WT . | SNORD . | WT . | SNORD . | WT . | SNORD . | WT . | SNORD . |
OF | 10.8 ± 1.2 | 11.2 ± 0.96 | 26 ± 3 | 25 ± 3 | 69 ± 10 | 45 ± 3* | 2.48 ± 0.2 | 2.36 ± 0.31 |
PL | 41 ± 5 | 29 ± 4 | 17 ± 2 | 16 ± 3 | 116 ± 8 | 86 ± 11* | 0.54 ± 0.08 | 0.55 ± 0.05 |
aCg | 89 ± 12 | 80 ± 7 | 75 ± 9 | 67 ± 7 | 213 ± 23 | 201 ± 24 | 0.79 ± 0.09 | 0.84 ± 0.08 |
NAC | 1591 ± 266 | 1544 ± 215 | 904 ± 136 | 1036 ± 109 | 601 ± 112 | 620 ± 59 | 0.6 ± 0.05 | 0.76 ± 0.11 |
DMS | 4107 ± 356 | 4535 ± 1047 | 1561 ± 162 | 1496 ± 195 | 670 ± 74 | 723 ± 143 | 0.36 ± 0.03 | 0.39 ± 0.04 |
DLS | 6064 ± 666 | 5028 ± 176 | 802 ± 92 | 790 ± 82 | 500 ± 60 | 448 ± 20 | 0.13 ± 0.01 | 0.15 ± 0.01 |
Th | 6 ± 0.9 | 8 ± 1 | 20 ± 1 | 22 ± 2 | 72 ± 8 | 77 ± 6 | 3.85 ± 0.58 | 2.67 ± 0.22 |
AM | 240 ± 54 | 287 ± 48.8 | 83 ± 19 | 121 ± 26 | 150 ± 22.6 | 215 ± 49 | 0.33 ± 0.05 | 0.46 ± 0.09 |
dH | 48 ± 6 | 44 ± 4 | 13 ± 1.8 | 13 ± 2 | 39 ± 3.78 | 41.8 ± 5.3 | 0.3 ± 0.03 | 0.3 ± 0.02 |
VTA | 215 ± 41 | 234 ± 38 | 191 ± 37 | 207 ± 27 | 205 ± 30.1 | 239 ± 18.8 | 0.88 ± 0.05 | 0.91 ± 0.06 |
SN | 259 ± 54 | 223 ± 46 | 141 ± 15 | 136 ± 21 | 265 ± 36 | 252 ± 40.3 | 0.64 ± 0.04 | 0.76 ± 0.04* |
vY | 128 ± 19 | 106 ± 14 | 105 ± 8 | 101 ± 13.1 | 171 ± 18.8 | 136 ± 16.9 | 0.98 ± 0.07 | 0.99 ± 0.08 |
. | DA . | DOPAC . | HVA . | DOPAC/DA . | ||||
---|---|---|---|---|---|---|---|---|
region . | WT . | SNORD . | WT . | SNORD . | WT . | SNORD . | WT . | SNORD . |
OF | 10.8 ± 1.2 | 11.2 ± 0.96 | 26 ± 3 | 25 ± 3 | 69 ± 10 | 45 ± 3* | 2.48 ± 0.2 | 2.36 ± 0.31 |
PL | 41 ± 5 | 29 ± 4 | 17 ± 2 | 16 ± 3 | 116 ± 8 | 86 ± 11* | 0.54 ± 0.08 | 0.55 ± 0.05 |
aCg | 89 ± 12 | 80 ± 7 | 75 ± 9 | 67 ± 7 | 213 ± 23 | 201 ± 24 | 0.79 ± 0.09 | 0.84 ± 0.08 |
NAC | 1591 ± 266 | 1544 ± 215 | 904 ± 136 | 1036 ± 109 | 601 ± 112 | 620 ± 59 | 0.6 ± 0.05 | 0.76 ± 0.11 |
DMS | 4107 ± 356 | 4535 ± 1047 | 1561 ± 162 | 1496 ± 195 | 670 ± 74 | 723 ± 143 | 0.36 ± 0.03 | 0.39 ± 0.04 |
DLS | 6064 ± 666 | 5028 ± 176 | 802 ± 92 | 790 ± 82 | 500 ± 60 | 448 ± 20 | 0.13 ± 0.01 | 0.15 ± 0.01 |
Th | 6 ± 0.9 | 8 ± 1 | 20 ± 1 | 22 ± 2 | 72 ± 8 | 77 ± 6 | 3.85 ± 0.58 | 2.67 ± 0.22 |
AM | 240 ± 54 | 287 ± 48.8 | 83 ± 19 | 121 ± 26 | 150 ± 22.6 | 215 ± 49 | 0.33 ± 0.05 | 0.46 ± 0.09 |
dH | 48 ± 6 | 44 ± 4 | 13 ± 1.8 | 13 ± 2 | 39 ± 3.78 | 41.8 ± 5.3 | 0.3 ± 0.03 | 0.3 ± 0.02 |
VTA | 215 ± 41 | 234 ± 38 | 191 ± 37 | 207 ± 27 | 205 ± 30.1 | 239 ± 18.8 | 0.88 ± 0.05 | 0.91 ± 0.06 |
SN | 259 ± 54 | 223 ± 46 | 141 ± 15 | 136 ± 21 | 265 ± 36 | 252 ± 40.3 | 0.64 ± 0.04 | 0.76 ± 0.04* |
vY | 128 ± 19 | 106 ± 14 | 105 ± 8 | 101 ± 13.1 | 171 ± 18.8 | 136 ± 16.9 | 0.98 ± 0.07 | 0.99 ± 0.08 |
All values are expressed as mean ± SEM (pg/mg of tissue for individual compounds) except the ratio. Significance is indicated as follows: *P < 0.05 (Students t-test). (n = 8–10 except in the DL where n = 5 due to an experimental error).
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.